Advertisements


EcoR– Capital, LLC Buys CytomX Therapeutics Inc, Cascadian Therapeutics Inc, Fate ...

Related Stocks: ACRS, LIFE, ATRA, BMY, CTMX, CASC, FATE, OVAS, JNCE, RGLS, F,.....»»

Category: personnelSource: nytMay 19th, 2017

Armistice Capital, Llc Buys Novelion Therapeutics Inc, Regeneron Pharmaceuticals Inc, Adamas ...

Related Stocks: VNDA, FRPT, NOMD, SGYP, KATE, DECK, NVLN, REGN, ADMS, HBI, T,.....»»

Category: worldSource: nytMay 15th, 2017

Abingworth LLP Buys Cascadian Therapeutics Inc, Aurinia Pharmaceuticals Inc, Immune Design ...

Related Stocks: IMDZ, CASC, AUPH, DRNA,.....»»

Category: blogSource: gurufocusMay 15th, 2017

Rubric Capital Management LP Buys Xperi, Braskem SA, Heron Therapeutics, Sells Olin, Signet ...

Related Stocks: BAK, HRTX, KRA, CNDT, GMS, MDCA, XPER, GPK, BYD, HRI, SNCR, R,.....»»

Category: personnelSource: nytApr 28th, 2017

Fate Therapeutics initiated with a Buy at Roth Capital

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual investors, professional money managers, active trader.....»»

Category: blogSource: theflyonthewallSep 22nd, 2016

Halozyme Therapeutics, Inc."s Necessary Move Sends Shares Down as Much as 10%

The need for fresh capital is a plight most drug developers face......»»

Category: topSource: foxnewsMay 19th, 2017

Should CytomX Therapeutics (CTMX) Be On Your Radar Now?

CytomX Therapeutics (CTMX) seems to be overlooked by shareholders .....»»

Category: topSource: zacksMay 16th, 2017

Fate Therapeutics" (FATE) CEO Scott Wolchko on Q1 2017 Results - Earnings Call Transcript

Fate Therapeutics" (FATE) CEO Scott Wolchko on Q1 2017 Results - Earnings Call Transcript.....»»

Category: topSource: seekingalphaMay 16th, 2017

Harbourvest Partners Llc Buys Proteostasis Therapeutics Inc, Nutanix Inc, Groupon Inc, Sells ...

Related Stocks: CTMX, PTI, NTNX, GRPN, SENS, TWLO, APTI, W, LC, BOX, FNJN, XL,.....»»

Category: personnelSource: nytMay 15th, 2017

13G Filing: Broadfin Capital and Aratana Therapeutics Inc. (PETX)

You can access the original SEC filing by clicking here. Ownership Summary Table Page 1 of 10 – SEC Filing UNITED STATES SECURITIE.....»»

Category: topSource: insidermonkeyMay 13th, 2017

EAM Investors, LLC Buys NewLink Genetics Corp, Teladoc Inc, Esperion Therapeutics Inc, Sells ...

Related Stocks: BRKS, FLXN, AQMS, DERM, SN, UCTT, NLNK, TDOC, ESPR, EXTR, TV,.....»»

Category: smallbizSource: nytMay 10th, 2017

Cascadian Therapeutics" (CASC) CEO Scott Myers on Q1 2017 Results - Earnings Call Transcript

Cascadian Therapeutics" (CASC) CEO Scott Myers on Q1 2017 Results - Earnings Call Transcript.....»»

Category: topSource: seekingalphaMay 9th, 2017

13G Filing: Adage Capital Management and Audentes Therapeutics Inc (BOLD)

You can access the original SEC filing by clicking here. Ownership Summary Table Page 1 of 12 – SEC Filing SECURITIES AND EXCHANGE CO.....»»

Category: topSource: insidermonkeyApr 29th, 2017

HealthInvest Partners AB Buys Aetna, Osiris Therapeutics, Achillion Pharmaceuticals, Sells ...

Related Stocks: AET, OSIR, ACHN, CRL, SUPN, CAH, TARO, ANTM, MRK, GTS,.....»»

Category: blogSource: gurufocusApr 28th, 2017

Selway Asset Management Buys Qualcomm, Marathon Petroleum, Celgene, Sells United Therapeutics, ...

Related Stocks: QCOM, PML, DKS, M, BHK, MPC, CELG, HAIN, KR, PII, HOG, DVMT,.....»»

Category: blogSource: gurufocusApr 27th, 2017

Hershey Trust Co Buys Momo, Vipshop Holdings, AMETEK, Sells Sage Therapeutics, JD. ...

Related Stocks: VIPS, WUBA, MYOK, MOMO, AME, SAGE, JD, EDIT, GBT, GKOS, HUBS,.....»»

Category: blogSource: gurufocusApr 25th, 2017

Meditor Group Ltd Buys Celldex Therapeutics, Sells VIVUS

Related Stocks: CLDX, VVUS,.....»»

Category: blogSource: gurufocusApr 24th, 2017

University Of Texas Investment Managment Co Buys Apollo Endosurgery, Miragen Therapeutics, ...

Related Stocks: APEN, MGEN, JNCE, PK, FISV, HD, HAL, MSFT, RETA, MBLY, FFIN,.....»»

Category: blogSource: gurufocusApr 20th, 2017

Chardan Still Skeptical Of Coversin, Reiterates Sell Rating On Akari Therapeutics

Madhu Kumar of Chardan Capital Markets maintains a Sell rating on Akari Therapeutics PLC (ADR) (NASDAQ: AKTX) ahead of the c.....»»

Category: blogSource: benzingaApr 17th, 2017

13D Filing: Kingstown Capital Partners, Llc and Novelion Therapeutics Inc. (NASDAQ:NVLN)

You can access the original SEC filing by clicking here. Ownership Summary Table Page 1 of 13 – SEC Filing UNITED STATES SECURITIE.....»»

Category: topSource: insidermonkeyApr 8th, 2017

Cara Therapeutics Is Scratching the Itch for Promising Biotechs

The latest trial results are a clear win, and the company will take the opportunity to raise some capital......»»

Category: topSource: foxnewsMar 31st, 2017